American Heart Journal
Volume 156, Issue 6 , Pages 1191-1195 , December 2008

Independent prognostic value of echocardiography and N-terminal pro–B-type natriuretic peptide in patients with heart failure

  • Alan L. Hinderliter, MD

      Affiliations

    • University of North Carolina, Chapel Hill, NC
    • Corresponding Author InformationReprint requests: Alan L. Hinderliter, MD, Division of Cardiology, University of North Carolina CB# 7075, Burnett-Womack Building, Chapel Hill, NC 27559-7075.
    • ,
  • James A. Blumenthal, PhD

      Affiliations

    • Duke University Medical Center, Durham, NC
    • ,
  • Christopher O'Conner, MD

      Affiliations

    • Duke University Medical Center, Durham, NC
    • ,
  • Kirkwood F. Adams, MD

      Affiliations

    • University of North Carolina, Chapel Hill, NC
    • ,
  • Carla Sueta Dupree, MD, PhD

      Affiliations

    • University of North Carolina, Chapel Hill, NC
    • ,
  • Robert A. Waugh, MD

      Affiliations

    • Duke University Medical Center, Durham, NC
    • ,
  • Daniel Bensimhon, MD

      Affiliations

    • Duke University Medical Center, Durham, NC
    • ,
  • Robert H. Christenson, PhD

      Affiliations

    • University of Maryland School of Medicine, Baltimore, MD
    • ,
  • Andrew Sherwood, PhD

      Affiliations

    • Duke University Medical Center, Durham, NC

Received 3 December 2007 ,Accepted 25 July 2008.

References 

  1. Grayburn PA, Appleton CP, DeMaria AN, et al. Echocardiographic predictors of morbidity and mortality in patients with advanced heart failure. J Am Coll Cardiol. 2005;45:1064–1071
  2. St John Sutton M, Pfeffer MA, Moye L, et al. Cardiovascular death and left ventricular remodeling two years after myocardial infarction: baseline predictors and impact of long-term use of captopril: information from the Survival and Ventricular Enlargement (SAVE) trial. Circulation. 1997;96:3294–3299
  3. Rihal CS, Nishimura RA, Hatle LK, et al. Systolic and diastolic dysfunction in patients with clinical diagnosis of dilated cardiomyopathy. Relation to symptoms and prognosis. Circulation. 1994;90:2772–2779
  4. Parameshwar J, Keegan J, Sparrow J, et al. Predictors of prognosis in severe chronic heart failure. Am Heart J. 1992;123:421–426
  5. Rossi A, Cicoira M, Zanolla L, et al. Determinants and prognostic value of left atrial volume in patients with dilated cardiomyopathy. J Am Coll Cardiol. 2002;40:1425–1430
  6. Ghio S, Recusani F, Klersy C, et al. Prognostic usefulness of tricuspid annular plane systolic excursion in patients with congestive heart failure secondary to idiopathic or ischemic dilated cardiomyopathy. Am J Cardiol. 2000;85:837–842
  7. Meluzin J, Spinarova L, Dusek L, et al. Prognostic importance of the right ventricular function assessed by Doppler tissue imaging. Eur J Echocardiogr. 2003;4:262–271
  8. Blondheim DS, Jacobs LE, Kotler MN, et al. Dilated cardiomyopathy with mitral regurgitation: decreased survival despite a low frequency of left ventricular thrombus. Am Heart J. 1991;122:763–771
  9. Koelling TM, Aaronson KD, Cody RJ, et al. Prognostic significance of mitral regurgitation and tricuspid regurgitation in patients with left ventricular systolic dysfunction. Am Heart J. 2002;144:524–529
  10. Doust JA, Pietrzak E, Dobson A, et al. How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic review. BMJ. 2005;330:625–633
  11. Lang RM, Bierig M, Devereux RB, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005;18:1440–1463
  12. Sherwood A, Blumenthal JA, Trivedi R, et al. Depression and antidepressant medication use affect mortality and hospitalization in patients with congestive heart failure. Arch Int Med. 2007;167:367–373
  13. Moller JE, Hillis GS, Oh JK, et al. Left atrial volume: a powerful predictor of survival after acute myocardial infarction. Circulation. 2003;107:2207–2212
  14. Gackowski A, Isnard R, Golmard JL, et al. Comparison of echocardiography and plasma B-type natriuretic peptide for monitoring the response to treatment in acute heart failure. Eur Heart J. 2004;25:1788–1796
  15. Dokainish H, Zoghbi WA, Ambriz E, et al. Comparative cost-effectiveness of B-type natriuretic peptide and echocardiography for predicting outcome in patients with congestive heart failure. Am J Cardiol. 2005;97:400–403
  16. Dokainish H, Zoghbi WA, Lakkis NM, et al. Incremental predictive power of B-type natriuretic peptide and tissue Doppler echocardiography in the prognosis of patients with congestive heart failure. J Am Coll Cardiol. 2005;45:1223–1226

 This study was supported by grant HL61784 from the National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, and grant M01-RR-30 from the General Clinical Research Center Program, National Center for Research Resources, National Institutes of Health.Guest Editor: Hector O. Ventora, MD.

PII: S0002-8703(08)00655-8

doi: 10.1016/j.ahj.2008.07.022

American Heart Journal
Volume 156, Issue 6 , Pages 1191-1195 , December 2008

Article Tools